Clinical trials
Phase 3 Leukemia, Myeloid, Acute trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 6 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 3 |
| Celgene | 2 |
| Eastern Cooperative Oncology Group | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Daiichi Sankyo | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Gamida Cell ltd | 1 |
| Gilead Sciences | 1 |
| Gruppo Italiano Trapianto di Midollo Osseo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 30 |
| Leukemia | 6 |
| Myelodysplastic Syndromes | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Leukemia, Erythroblastic, Acute | 3 |
| Leukemia, Megakaryoblastic, Acute | 3 |
| Leukemia, Monocytic, Acute | 3 |
| Leukemia, Myelomonocytic, Acute | 3 |
| Neoplasms | 3 |
| Anemia, Refractory, with Excess of Blasts | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.